The variant affects gene GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D), which is on Chromosome 19. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary.
Pathogenic; Developmental and epileptic encephalopathy, 46